Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-30

Clinical Trial Update: Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the impact of short-term initiation of basal insulin on 1-year glycemic control in people newly diagnosed with Type 2 diabetes; trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Basal insulin (short-term initiation) (insulin)

Snippet

Sponsor: University of Basrah | Conditions: Type2diabetes | Phase 3 | Status: COMPLETED